Pharma & Biotech

Viking Therapeutics has filed a mandatory disclosure with the U.S. Securities and Exchange Commission (SEC) detailing the compensation package for...

A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...

The Danish pharmaceutical giant Novo Nordisk is navigating a complex period marked by operational restructuring and legal scrutiny. As the...

Investors in Bionxt Solutions witnessed a dramatic rally in the company's share price last Friday, with the stock more than...

Pfizer is undertaking a profound corporate transformation, divesting billions in legacy holdings to reshape its future. However, this influx of...

The leadership at Healwell AI has laid out a definitive roadmap for 2026, signaling a crucial shift in corporate strategy....

Investor attention has returned to BioNxt Solutions following the release of encouraging new laboratory data. The company's latest preclinical study...

BioNxt Solutions is taking decisive action to improve its financial standing. The biotechnology firm has arranged to convert over CAD...

Tilray Brands, Inc. has reinforced its commitment to the European medical cannabis sector through a strategic reorganization in Italy, a...

BioNxt Solutions has unveiled two significant strategic developments this week, targeting both its financial structure and its core product pipeline....